BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 17136903)

  • 1. Prisoners who inject drugs: public health and human rights imperatives.
    Jürgens R; Betteridge G
    Health Hum Rights; 2005; 8(2):46-74. PubMed ID: 17136903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of safer injection facilities in reducing HIV and hepatitis C infections and overdose mortality in the United States.
    Semaan S; Fleming P; Worrell C; Stolp H; Baack B; Miller M
    Drug Alcohol Depend; 2011 Nov; 118(2-3):100-10. PubMed ID: 21515001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy.
    Elliott R; Csete J; Wood E; Kerr T
    Health Hum Rights; 2005; 8(2):104-38. PubMed ID: 17136905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Jailbreak Health Project--incorporating a unique radio programme for prisoners.
    Minc A; Butler T; Gahan G
    Int J Drug Policy; 2007 Oct; 18(5):444-6. PubMed ID: 17854735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV, harm reduction and human rights.
    CMAJ; 2005 Mar; 172(5):605, 607. PubMed ID: 15738469
    [No Abstract]   [Full Text] [Related]  

  • 8. Opportunities to address the hepatitis C epidemic in the correctional setting.
    Boutwell AE; Allen SA; Rich JD
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S367-72. PubMed ID: 15768350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tattooing in prisons--not such a pretty picture.
    Hellard ME; Aitken CK; Hocking JS
    Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The furthest left behind: the urgent need to scale up harm reduction in prisons.
    Sander G; Murphy F
    Int J Prison Health; 2017 Sep; 13(3-4):185-191. PubMed ID: 28914120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harm reduction: closing the distance.
    CMAJ; 2001 Aug; 165(4):389, 391. PubMed ID: 11531042
    [No Abstract]   [Full Text] [Related]  

  • 12. Indonesian prisons and HIV: part of the problem, part of the solution?
    Nelwan EJ; Diana A; van Crevel R; Alam NN; Alisjahbana B; Pohan HT; van der Ven A; Djaya I
    Acta Med Indones; 2009 Jul; 41 Suppl 1():52-6. PubMed ID: 19920299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Global State of Harm Reduction in Prisons.
    Sander G; Shirley-Beavan S; Stone K
    J Correct Health Care; 2019 Apr; 25(2):105-120. PubMed ID: 31084277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. People who inject drugs in prison: HIV prevalence, transmission and prevention.
    Dolan K; Moazen B; Noori A; Rahimzadeh S; Farzadfar F; Hariga F
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S12-5. PubMed ID: 25727258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkage with methadone treatment upon release from incarceration: a promising opportunity.
    Rich JD; McKenzie M; Shield DC; Wolf FA; Key RG; Poshkus M; Clarke J
    J Addict Dis; 2005; 24(3):49-59. PubMed ID: 16186082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
    Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
    Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.
    Mohtasham Amiri Z; Rezvani M; Jafari Shakib R; Jafari Shakib A
    East Mediterr Health J; 2007; 13(2):250-6. PubMed ID: 17684845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Audit into blood-borne virus services in Her Majesty's Prison Service.
    Murray E; Jones D
    Int J STD AIDS; 2008 May; 19(5):347-8. PubMed ID: 18482968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
    Chakrapani V; Kamei R; Kipgen H; Kh JK
    Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.